Published in Arch Virol Suppl on January 01, 1994
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol (2001) 2.81
West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol (2006) 2.79
Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol (2004) 2.45
Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol (2000) 1.81
Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.38
Formation and characterization of the trimeric form of the fusion protein of Semliki Forest Virus. J Virol (2000) 1.31
Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J Virol (1997) 1.24
Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J Virol (2001) 1.12
Replication cycle and molecular biology of the West Nile virus. Viruses (2013) 1.03
Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol (2003) 1.02
A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology (2012) 0.94
Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate. J Gen Virol (2011) 0.91
NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition. Protein Sci (2006) 0.85
Distinct variation in vector competence among nine field populations of Aedes aegypti from a Brazilian dengue-endemic risk city. Parasit Vectors (2014) 0.83
Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines. P R Health Sci J (2009) 0.75
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer (1996) 3.30
Cloning and expression of a chitinase gene from the hyperparasitic fungus Aphanocladium album. Curr Genet (1992) 3.24
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A (1996) 2.81
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer (2000) 2.73
Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques (1991) 2.64
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Structures and mechanisms in flavivirus fusion. Adv Virus Res (2000) 2.36
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet (1989) 2.22
Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer (1999) 2.19
The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health (2001) 2.18
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology (1995) 2.08
Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer (1997) 2.06
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med (1998) 1.75
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett (1999) 1.68
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
[Studies of the mechanism of the activity diminution of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. I]. Arch Klin Exp Dermatol (1967) 1.61
Prevention of tumour cell dissemination in diagnostic needle procedures. Br J Cancer (2010) 1.57
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology (1983) 1.53
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Laboratory findings in tick-borne encephalitis--correlation with clinical outcome. Infection (2000) 1.46
Loss of a histidine residue at the active site of S-locus ribonuclease is associated with self-compatibility in Lycopersicon peruvianum. Proc Natl Acad Sci U S A (1994) 1.46
Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol (1997) 1.45
Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol (1991) 1.38
Human milk oligosaccharides are minimally digested in vitro. J Nutr (2000) 1.35
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine (1990) 1.35
[Remarks on the stroma reaction in melanoma]. Med Welt (1967) 1.35
PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br J Cancer (2007) 1.34
Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol (1996) 1.34
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
[Dehydroepiandrosterone deficiency in psoriasis. Hypothesis on the etiopathogenesis of this disease]. Hautarzt (1980) 1.31
Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol (1996) 1.28
Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis (1980) 1.27
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine (1997) 1.26
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst (1999) 1.25
Reconstruction of orbital wall defects: critical review of 72 patients. Int J Oral Maxillofac Surg (2007) 1.24
Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res (1984) 1.23
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res (1996) 1.23
Epithelial-myoepithelial duct carcinoma of salivary glands: a follow-up and cytophotometric study of 21 cases. J Oral Pathol Med (1989) 1.23
Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology (1984) 1.23
Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR. Virus Genes (1994) 1.21
Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J Virol (1987) 1.20
Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med (1990) 1.20
A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol (1990) 1.19
Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg (1992) 1.19
Chemical crosslinking of tick-borne encephalitis virus and its subunits. J Gen Virol (1980) 1.19
An ongoing multi-state outbreak of measles linked to non-immune anthroposophic communities in Austria, Germany, and Norway, March-April 2008. Euro Surveill (2008) 1.18
Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine (2001) 1.18
West Nile virus vaccine. Curr Drug Targets Infect Disord (2001) 1.18
A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol (1999) 1.17
Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol (1981) 1.17